To survey the conduct of intraparenchymal intracranial pressure (ICP) monitoring in hospitals with no neurosurgical service on-site.
Results
All 18 units responded and represented a broad cross-section of ICUs in the UK. Traumatic brain injury (94% of ICUs) and intracranial haemorrhage (61%) were the most frequent reasons for instituting ICP monitoring. Seventeen of the 18 units used accepted guideline indications for ICP monitoring in patients with a severe head injury and an abnormal scan, but only 2 ICUs (11%) followed these guidelines when the comatose head-injured patient had a normal scan. Only two minor wound haemorrhages had complicated the total experience of the 18 units (estimated at around 1000 catheters). One unit allowed SHOs to insert the ICP catheter and one region has developed a training programme with the involvement of neurosurgeons. One ICU could not display the ICP waveform in the bed-space and 7 units (39%) were unable to display and readily interpret ICP trend data.
Subsequent extension of the questionnaire revealed that no units in Scotland or Northern Ireland are monitoring ICP without a neurosurgical service on-site.
Conclusions
There is a marked variation in the conduct of ICP monitoring in acute hospitals with no neurosurgical service on-site. This variation could be reduced by increasing the involvement of neurosurgeons in the processes of training, clinical guidelines and audit. This simple assessment suggests that the procedure of inserting intraparenchymal ICP monitors in non-neurosurgical centres is associated with a low complication rate. Our survey suggests that intraparenchymal ICP monitoring is achievable and safe in non-neurosurgical centres and therefore the existing recommendation that the care of all severe head injuries should only be performed in neurosurgical centres may require re-evaluation. These results suggest that further prospective analysis of monitoring intraparenchymal ICP and managing selected patients with severe brain injury in non-neurosurgical centres is warranted. Intraparenchymal ICP monitoring is considered to be the optimal method of ICP monitoring when an external ventricular drain is not indicated 3 
Results
We obtained responses from 100% of the 18 eligible ICUs in England and Wales.
ICU demographics and relationship with the nearest neurosurgical unit
The median ICU size was 10 beds (range 5 to 20) and the units admitted between 200 and 1200 (median 800) patients per annum. The nearest neurosurgical unit was located less than 50 miles from 17 of the 18 ICUs, but one ICU was located over 100 miles from a neurosurgical centre (median 50 miles). The median transfer time by road was 28 minutes (range 5 to 160 minutes), with 3 units frequently using helicopter transport, which takes on average 30 minutes.
Prior to transfer, information was conveyed by telephone and telemetry of the CT scan in all cases. One unit also used fax and two can get a rapid neurosurgical opinion in person. No unit used e-mail or computerised physiological data transmission.
ICP monitoring
Exactly half of the ICUs used each type of monitor and 15 units had been monitoring ICP for 3 years or more (range 6 months to 10 years, median 4 years). The number of ICP monitors inserted by each unit per annum varied considerably (Table 1 ) and although some units demonstrated considerable usage, nine ICUs insert 5 or fewer monitors each year. Extrapolation of the data shows that the total numbers of intraparenchymal ICP monitors inserted in non-neurosurgical centres is in the order of 120 to more than 200 per annum. 
Concordance with current guidelines
Concordance with Brain Trauma Foundation guidelines for ICP monitoring in traumatic brain injury (without identifying the source of these potential indications) was shown to be good for the most common indication (coma with an abnormal scan) with only one ICU not using the indication. However concordance with the other two indications was poor (see Table 2 ).
Other specific indications volunteered by individual ICUs were alcohol ingestion, abnormal CT appearances, multiply injured patients, decreased level of consciousness but not necessarily to below GCS 8, clinical deterioration despite GCS, younger patients and ventilated patients with an unknown GCS.
Indications for ICP monitoring
The commonest indication for ICP monitoring was traumatic brain injury (94% of ICUs), followed by intracranial haemorrhage (61%). Less common indications were infective (39%), hypoxic (33%) or metabolic (44%) brain Table 3 ).
Scotland and Northern Ireland
Subsequent extension of this questionnaire revealed that no units without on-site neurosurgical facilities conducted intraparenchymal ICP monitoring in Scotland and Northern Ireland.
Discussion

Principal findings
The current European and American guidelines for ICP monitoring and management of head injuries recommend that ICP monitoring and management of severe traumatic brain injury should be conducted in neurosurgical units. However, in 1998 a UK survey revealed that approximately 2100 patients with severe head injury were admitted to ICUs in nonneurosurgical centres 4 This study suggests that ICP monitoring in non-neurosurgical centres is being safely conducted with low complication rates.
Using the reported rate of ICP catheter usage and the duration of their use in each unit, 2 episodes of haemorrhage out of an estimated 1082 catheters inserted equates to a 0.18% rate of significant complication. This compares 
Transcranial doppler 0 (0) 
Strengths and Weaknesses
Although the number of respondents to this survey is small, this questionnaire achieved a 100% return rate of its target ICUs. The authors knew the target ICUs were small in number so the questionnaire was designed to have as few open or leading questions as possible and to maximise the number of closed questions. Therefore, it is a reasonable description of the current conduct of intraparenchymal ICP monitoring in non-neurosurgical centres.
Implications
There is some evidence that delaying insertion of an ICP monitor until arrival in the neurosurgical unit results in a clinically significant delay that may result in a secondary brain injury 6 . It is possible that commencement of ICP monitoring prior to transfer might be an improved management strategy for STBI cases proven to have no surgical mass lesion.
Unanswered Qs and future research
The precise roles of some specific neurosurgical interventions, such as decompressive craniectomy or placement of an external ventricular drain remain unproven. Likewise, it remains unproven whether or not transfer of STBI cases to specialist centres actually improves outcome once a lesion amenable to neurosurgery has been excluded.
This form of data collection relies upon self-reporting by interested individual clinicians and has not focused on longer term patient outcomes following ICP monitoring. Prospective analysis of practice and outcomes may provide a more accurate picture of ICP monitoring and allow review, and more effective implementation, of existing guidelines.
EBM for specialist neurocritical care
There is considerable variation in the management of patients with STBI within the USA and UK4, 7 . Attempts have been made to determine if management of STBI using specialist neurocritical care improves outcome [8] [9] [10] [11] . Although these studies have used historical controls, they appear to suggest that the use of protocol-based management that includes ICP monitoring and control does alter outcome. To date there is no evidence that all of these patients should be managed in a specialist neurocritical care unit or in a hospital that has a neurosurgical service. It remains uncertain whether patients with a diffuse brain injury actually benefit from transfer to a hospital with a neurosurgical unit rather than remain in a general ICU that provides protocol-based management and liases closely with neurosurgeons.
Conclusion
ICP monitoring is being safely conducted in non-neurosurgical centres. Existing recommendations that ICP monitoring should only be performed in neurosurgical centres may require re-evaluation. s
